Repligen Announces Agreement to Acquire Engineered Molding Technology
WALTHAM, Mass., June 29, 2020 (GLOBE NEWSWIRE) — Repligen Corporation (NASDAQ:RGEN), a life sciences company focused on bioprocessing technology leadership, […]
Organogenesis Holdings Inc. to Report Second Quarter of Fiscal Year 2020 Financial Results on August 10, 2020
CANTON, Mass., June 29, 2020 (GLOBE NEWSWIRE) — Organogenesis Holdings Inc. (Nasdaq: ORGO), a leading regenerative medicine company focused on […]
Kiniksa Announces Positive Data from Phase 3 Trial of Rilonacept in Recurrent Pericarditis (RHAPSODY)
Primary and all major secondary efficacy endpoints were highly statistically significant Rilonacept treatment resulted in a 96% reduction in risk of […]
Resonant Inc. to Join Russell 2000® and 3000® Indexes
GOLETA, Calif., June 29, 2020 (GLOBE NEWSWIRE) — Resonant Inc. (NASDAQ: RESN), a leader in transforming the way radio frequency, […]
Ultralife Corporation Announces Addition to the Russell 2000® Index
NEWARK, N.Y., June 29, 2020 (GLOBE NEWSWIRE) — Ultralife Corporation (NASDAQ: ULBI) today announced it has been added to the […]
Tonix Pharmaceuticals Announces Enrollment of Phase 3 RELIEF Trial of TNX-102 SL for Management of Fibromyalgia is Ahead of Schedule
Topline Results Expected Fourth Quarter 2020 Due to Faster than Previously Projected EnrollmentCompletion of Trial Enrollment Anticipated Early Third Quarter […]
GenMark Diagnostics Announces Commercial Launch of its ePlex® Respiratory Pathogen Panel 2 (RP2)
CARLSBAD, Calif., June 29, 2020 (GLOBE NEWSWIRE) — GenMark Diagnostics, Inc. (NASDAQ:GNMK), a leading provider of automated, multiplex molecular diagnostic […]
Intercept Receives Complete Response Letter from FDA for Obeticholic Acid for the Treatment of Fibrosis Due to NASH
NEW YORK, June 29, 2020 (GLOBE NEWSWIRE) — Intercept Pharmaceuticals, Inc. (Nasdaq:ICPT), a biopharmaceutical company focused on the development and […]
Sol-Gel Technologies Announces Agreements with Perrigo Company for Three New Generic Product Candidates
NESS ZIONA, Israel, June 29, 2020 (GLOBE NEWSWIRE) — Sol-Gel Technologies, Ltd. (NASDAQ: SLGL), a clinical-stage dermatology company focused on […]
Aprea Therapeutics Appoints Fouad Namouni, M.D. and Richard Peters, M.D., Ph.D. to Board of Directors
BOSTON, June 29, 2020 (GLOBE NEWSWIRE) — Aprea Therapeutics Inc., (NASDAQ: APRE), a clinical-stage biotechnology company focused on developing and […]
